Phase 1 Novel Live Attenuated Serotype 2 Oral Polio Vaccine Study in Inactivated Polio Vaccine (IPV) Primed Adults

NCT03430349 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Poliomyelitis

Interventions

BIOLOGICAL: Novel OPV2 candidate 1
BIOLOGICAL: Novel OPV2 candidate 2

Sponsor

Pierre Van Damme

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]